Stockscreener 앱 받기
0.6062
10.22%
-0.069
시간 외 거래:
.61
0.0038
+0.63%
전일 마감가:
$0.6752
열려 있는:
$0.6592
하루 거래량:
2.06M
Relative Volume:
0.28
시가총액:
$6.50M
수익:
$5.75M
순이익/손실:
$-38.96M
주가수익비율:
-0.0486
EPS:
-12.47
순현금흐름:
$-32.63M
1주 성능:
-27.69%
1개월 성능:
-14.15%
6개월 성능:
-85.90%
1년 성능:
-90.19%
1일 변동 폭
$0.60
$0.667
1주일 범위
$0.60
$0.8642
52주 변동 폭
$0.60
$20.60
칼라 파마슈티컬스 Stock (KALA) Company Profile
명칭
Kala Bio Inc
전화
781-996-5252
주소
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
KALA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.6062 | 7.24M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
칼라 파마슈티컬스 Stock (KALA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-09-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | 개시 | Mizuho | Outperform |
| 2025-07-11 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-14 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-07-23 | 개시 | Northland Capital | Outperform |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2020-05-27 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 개시 | Jefferies | Buy |
모두보기
칼라 파마슈티컬스 주식(KALA)의 최신 뉴스
Can Sobha Limited Maintain Its Share of Global Market for Its ProductUtilities Sector Analysis & Affordable Portfolio Trading - earlytimes.in
Top Penny Stocks To ResearchDecember 4th - MarketBeat
What drives KALA BIO Inc stock priceSmall Cap Stock Opportunities & Low Risk Wealth Plans - earlytimes.in
You might want to take a look at Kala Bio Inc (KALA) now - setenews.com
Kala Bio enters securities purchase agreement with David Lazar, names him CEO - MSN
Kala Bio Shares Jump After $6 Million Funding Deal With Investor David Lazar - MSN
KALA BIO Raises $10M in Direct Offering - TipRanks
KALA BIO closes $10 million registered direct offering - Investing.com India
KALA BIO Raises $10 Million From Direct Offering - marketscreener.com
KALA BIO closes $10 million registered direct offering By Investing.com - Investing.com South Africa
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO (NASDAQ: KALA) completes $10 million offering of 10,000,000 shares to repay debt - Stock Titan
Will KALA BIO Inc. stock continue upward momentumMarket Risk Summary & Community Consensus Picks - Newser
Kala Bio raises $10 million in registered direct offering By Investing.com - Investing.com Nigeria
KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update - ts2.tech
KALA BIO, Inc. (KALA) Stock: Surges 21.62% Amid Exciting New Offering Announcement - parameter.io
KALA Bio (KALA) Announces $10 Million Direct Stock Offering - GuruFocus
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors - ts2.tech
Kala Bio announces $10 mln registered direct offering of common stock - marketscreener.com
Kala Bio Reports $10 Million Direct Stock Offering; Shares Rise - marketscreener.com
Kala Bio raises $10 million in registered direct offering - Investing.com
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
KALA BIO Announces $10 Million Registered Direct Offering - GlobeNewswire
KALA Bio’s Bold Move: A New Dawn? - timothysykes.com
Aug Mood: Will KALA BIO Inc stock continue upward momentumTrade Analysis Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Will KALA BIO Inc. stock split attract more investors2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
KALA BIO, Inc. (KALA) -10.9% in Intraday Trading: Shares Decline Amid Routine Activity - Stocks Telegraph
Top Small Cap Stocks To Follow Today – December 1st - Defense World
Is KALA BIO Inc. stock a buy before product launchesJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
No data: Challenges Affecting KALA Stock Movements - StocksToTrade
An analyst sees good growth prospects for Kala Bio Inc (KALA) - Setenews
KALA BIO's $6M Leadership Turnaround Boosts Shares - Mena FN
KALA BIO Inc. (KALA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kala Bio secures $6 million investment as CEO changes amid trial failure By Investing.com - Investing.com Australia
KALA Stock Soars: Buying Opportunity? - StocksToTrade
KALA BIO, Inc. (KALA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Crude Oil Gains Over 1%; ISM Manufacturing PMI Falls In November - Benzinga
Dow Dips 200 Points; Q32 Bio Shares Jump - Benzinga
Kala Bio stock soars after $6M investment from David Lazar By Investing.com - Investing.com Nigeria
KALA’s Unexpected Surge: Unpacking the Recent Spike - timothysykes.com
Kala Bio enters into $6 million securities purchase agreement with investor David E. Lazar - marketscreener.com
KALA Secures $6M Investment, Appoints New CEO - GuruFocus
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Manila Times
KALA BIO, Inc. Announces $6 Million Securities Purchase Agreement and Appointment of David E. Lazar as CEO - Quiver Quantitative
KALA BIO (NASDAQ: KALA) inks $6M securities deal, appoints David Lazar CEO and chair - Stock Titan
칼라 파마슈티컬스 (KALA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
칼라 파마슈티컬스 주식 (KALA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 22 '25 |
Sale |
0.83 |
32,230 |
26,751 |
29,873 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 23 '25 |
Sale |
0.82 |
967 |
793 |
28,906 |
| Bazemore Todd | Director |
Oct 22 '25 |
Sale |
0.83 |
47,768 |
39,647 |
35,932 |
| Brazzell Romulus K | SEE REMARKS |
Oct 22 '25 |
Sale |
0.83 |
46,748 |
38,801 |
35,952 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Oct 22 '25 |
Sale |
0.83 |
20,806 |
17,269 |
41,760 |
0.36%
1.05%
자본화:
|
볼륨(24시간):